Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 0.6% on Wednesday after Wells Fargo & Company raised their price target on the stock from $210.00 to $240.00. Wells Fargo & Company ...

cementing its reputation as a dependable dividend payer. Valued at $358 billion, AbbVie stock is down 14% year-to-date.

Shares of AbbVie Inc. (NYSE:ABBV – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the ...

As Wall Street’s broader market averages continue to decline on Tuesday, following Monday’s significant sell-off, the idea of ...

From breakthrough treatments to AI-driven diagnostics, healthcare is evolving faster than ever. With increasing healthcare ...

Discover 10 dividend stocks with strong performance in 2025. Ranked by YTD returns, these stocks excel in safety, growth, yield & consistency.

Don't discount the power of momentum. Some studies have found that momentum trading -- buying stocks or exchange-traded funds ...

President Trump said tariffs on Mexico and Canada will go into effect on March 4. He added that tariffs on China will see a ...

After two years in the shadows, health stocks are back as a haven for investors navigating economic uncertainty.

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...

Stock market investors have enjoyed strong annual returns over the past two years, but analysts caution that 2025 may not ...